Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:16-23
Published online before print November 21, 2007, doi: 10.1161/STROKEAHA.107.484618
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/1/16    most recent
STROKEAHA.107.484618v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touzé, E.
Right arrow Articles by Rothwell, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touzé, E.
Right arrow Articles by Rothwell, P. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Clinical genetics
Right arrow Epidemiology
Right arrow Genetics of Stroke

(Stroke. 2008;39:16.)
© 2008 American Heart Association, Inc.


Original Contributions

Sex Differences in Heritability of Ischemic Stroke

A Systematic Review and Meta-Analysis

Emmanuel Touzé, MD, PhD Peter M. Rothwell, MD, PhD, MRCP

From the Stroke Prevention Research Unit (E.T., P.M.R.), University Department of Clinical Neurology, Radcliffe Infirmary, Oxford, UK; and Université Paris-Descartes (E.T.), Paris 5, EA4055, Department of Neurology, Centre Hospitalier Sainte-Anne, Paris, France.

Correspondence to Peter M. Rothwell, Stroke Prevention Research Unit, University Department of Clinical Neurology, Radcliffe Infirmary, Oxford OX2 6HE, UK. E-mail peter.rothwell{at}clneuro.ox.ac.uk


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose— Using data from Oxfordshire, UK, we recently showed that women are more likely than men to have a family history of stroke in female versus male first degree relatives. To test the generalizability of this finding, we did a comprehensive systematic review of all available published and unpublished data.

Methods— Studies were included in the present review if they reported the frequency of family history of stroke in relation to sex of parent or proband. Where necessary, we contacted authors of studies to obtain unpublished data. Data from the Oxford Vascular Study (OXVASC) and 3 other Oxford cohorts (1925 patients) were secondarily pooled with the data from other studies.

Results— We obtained data from 18 studies (7941 patients), including unpublished data from 7 studies. Female probands were slightly more likely to have a parental history of stroke than male probands (pooled OR=1.15; 95% CI: 1.03 to 1.29; P(sig)=0.028; P(het)=0.45). Maternal history of stroke was more common than paternal history (pooled OR=1.25; 1.15 to 1.37; P(sig)<0.00001; P(het)=0.12). However, the maternal excess was only present in female probands (pooled OR=1.47; 1.27 to 1.70; P(sig)<0.00001; P(het)=0.11). In contrast, male probands were no more likely to have maternal than paternal history of stroke (pooled OR=1.02; 0.88 to 1.17, P(sig)=0.43; P(het)=0.09).

Conclusions— Women with stroke are more likely than men to have a parental history of stroke, which is accounted for by an excess maternal history of stroke. This finding could be explained by sex-specific genetic, epigenetic, or nongenetic mechanisms.


Key Words: cerebrovascular accident • epidemiology • genetics • risk factors • family history


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Several studies have shown that ischemic stroke is, at least in part, a heritable disease.1,2 However, the relative importance of genetic and environmental factors is uncertain. Although some genetic polymorphisms have been associated with stroke,3,4 the mechanisms remain to be determined and most of the subsequent studies have failed to replicate the findings.5 In fact, heritability of stroke could also be explained by inheritance of intermediate phenotypes,6,7 or by exposure to early life environmental factors.8 The transmission of stroke in families is clearly not in accordance with a classic mode of inheritance. However, whether or not transmission of stroke could be sex-specific has been very rarely investigated. Yet, it cannot be assumed that heritability will necessarily be similar in both sexes. First, there are differences between stroke in males and females in relation to risk factors, frequency of subtypes, and outcome, which could reflect transmission of sex-specific factors.9 Second, several epidemiological studies have suggested that the risk of future vascular disease and that of vascular risk factors development could be programmed during the fetal life.10,11 An ecological correlation between low birth weight and risk of later coronary artery disease, hypertension, type 2 diabetes, and stroke notably supports this latter hypothesis.8,10 Greater maternal-offspring transmission of type 2 diabetes is also well established.12

Using data from the Oxford Vascular Study (OXVASC) population-based study, we have recently shown that women are more likely than men to have a history of stroke in mothers than in fathers and in sisters than in brothers.13 This female excess in women was independent of traditional vascular risk factors and was also found in 2 independent datasets from previous Oxford studies. However, the mechanisms of such a transmission remain unclear and the generalizability of the finding to other populations needs to be tested. Therefore, in collaboration with many original investigators who provided us unpublished data on family history, we did a comprehensive systematic review and meta-analysis of all available data.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
We sought all available previous published studies in which family history of stroke was analyzed as a risk factor for stroke or TIA, as reported elsewhere.1 Briefly, studies were identified by 2 independent observers from MEDLINE and EMBASE from 1966 with the following search terms: (family history OR twin) AND (stroke OR cerebrovascular accident OR TIA OR cerebrovascular OR transient ischemic attack). We considered studies in any language. The electronic literature search was updated using the same search terms until October 1st, 2006 and supplemented by hand-searching of reference lists, reviews, and specialist journals. Studies which had a high proportion of patients with hemorrhagic stroke but for which data were not available for ischemic stroke separately were excluded. Case-control, cohort, twin, and case studies were included in the current review if they reported the frequency of a parental history of stroke in relation to sex of parent or proband. Two independent reviewers used a standardized form to extract available data on family history separately for mother, father, and female and male probands.

We contacted authors of studies published within the last 10 years that reported parental history of stroke but which lacked sex-specific data and asked them to provide data on family history in father and mother separately for male and female probands. Apart from the OXVASC study, no study has reported on family history in sisters and brothers separately. In addition, analyses on siblings would have required obtaining individual data to take into account intrafamily correlations. Therefore, we did not seek data on siblings from authors.

Data from the OXVASC study,13,14 the Oxfordshire Community Stroke Project (OCSP),15 and those of Oxford hospital-referred TIA patients (TIA-series)6 were analyzed separately and secondarily pooled with the other data.

Statistical Analysis
Odds ratios (OR) for positive family history of stroke in women versus men and in mother versus father were calculated in all individual studies. In the comparison between the prevalence of maternal and paternal history of stroke, to avoid confounding attributable to any differences in characteristics between male and female probands, we used a paired analysis, OR simply being the ratio between the number of probands with a maternal history of stroke and the number of those with a paternal history.16 However, we also performed a separate analysis comparing the prevalence of parental history of stroke in female and in male probands using a nonpaired analysis. OR from separate studies were combined by fixed-effects meta-analysis according to the Mantel-Haenszel method which is also valid for paired-OR.16 Heterogeneity between studies was assessed by the Breslow-Day {chi}2 test and I2 statistic.17 The I2 statistic describes the percentage of total variation across studies that is attributable to heterogeneity rather than chance. Compared with the classical Breslow-Day {chi}2 test, its interpretation is more intuitive and the value does not depend on the number of studies. There is no simple categorization of values of I2 although values over 75% are usually considered as meaning high heterogeneity.17


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
We identified 28 studies which were potentially relevant for the present systematic review (22 from our previous systematic review and 6 among 267 references obtained from the updated electronic search). We contacted authors of 17 studies published ≥1995 with no (n=13) or partial (n=4) data in relation to parent or proband sex. Authors of 4 studies provided all requested data,18–21 3 gave partial data,22,23,24 2 did not collect the necessary data,25,26 and 8 did not reply. Thus, we obtained data from 18 studies (10 case–control studies, 4 case series, and 4 cohort studies), including unpublished data from 7 studies (Table 1). Family history information was obtained by structured interview in 11 studies, 18–22,24,27–31 death certificates in 4 studies,32–35 self-administered questionnaire in 2 studies,23,36 and the method used to collect this information was not given in 1 study.37 The main characteristics of Oxford studies are also given in Table 1.13


View this table:
[in this window]
[in a new window]

 
Table 1. Main Characteristics of Oxford Data, and the Other Studies Included in the Systematic Review (Published and Unpublished Data)

There was no significant difference between female and male probands in the prevalence of family history of stroke in any parent in Oxford data (OR=1.13; 0.90 to 1.41; Figure 1) and in other data from 9 studies (4042 patients, unpublished data from 6 studies; OR=1.16; 95% CI, 0.99 to 1.32; P=0.05; Figure 1). The pooled analysis showed that female probands were slightly, but significantly, more likely to have a positive family history of stroke in any parent than male probands (pooled OR=1.15; 1.03 to 1.28, P=0.028; Figure 1) with no heterogeneity across studies. In Oxford data, a maternal history of stroke was more common than a paternal history (Figure 2). Separate data for maternal and paternal history of stroke were available from 17 further studies (5710 patients, unpublished data from 3 studies). There was also a maternal excess of stroke in these studies (OR=1.21; 1.10 to 1.34; Figure 2). The pooled analysis showed a significant excess of maternal history of stroke (pooled OR=1.25; 1.15 to 1.37; Figure 2) without significant heterogeneity across studies.


Figure 1484618
View larger version (19K):
[in this window]
[in a new window]

 
Figure 1. Any parental history of stroke in women vs men. Unpublished data are in bold. Heterogeneity: the probability value corresponds to the Breslow-Day test.


Figure 2484618
View larger version (27K):
[in this window]
[in a new window]

 
Figure 2. Maternal vs paternal history of stroke. Unpublished data are in bold. Heterogeneity: the probability value corresponds to the Breslow-Day test.

However, as shown in Figures 3 and 4Down, the maternal excess was only present in female probands in Oxford cohorts (OR=2.03; 1.50 to 2.76). Although smaller, a similar excess was found in data from 8 studies identified in the literature from which data stratified by both sex of proband and sex of affected parent(s) were available (2002 women, unpublished data from 4 studies): OR=1.29 (1.12 to 1.56, P=0.0004). The pooled analysis of all available data showed that women were more likely to have a maternal than a paternal history of stroke (OR=1.47; 1.27 to 1.70) with no significant heterogeneity across studies. Figures 3 and 4Down also shows that, in contrast to female probands, male probands were no more likely to have maternal than paternal history of stroke in either the Oxford cohorts or in the other available studies (1967 patients from 8 studies, including unpublished data from 4 studies): pooled OR=1.02 (0.88 to 1.17).


Figure 3484618
View larger version (21K):
[in this window]
[in a new window]

 
Figure 3. Maternal vs paternal history of stroke in female probands. Unpublished data are in bold. Heterogeneity: the probability value corresponds to the Breslow-Day test.


Figure 4484618
View larger version (20K):
[in this window]
[in a new window]

 
Figure 4. Maternal vs paternal history of stroke in male probands. Unpublished data are in bold. Heterogeneity: the probability value corresponds to the Breslow-Day test.

In the nonpaired analyses, comparing female and male probands, females were more likely than males to have a maternal history of stroke (OR=1.42; 1.22 to 1.66, P(sig)<0.00001, P(het)=0.52), whereas they were no more likely to have a paternal history of stroke than males (OR=0.87, 0.74 to 1.03; P(sig)=0.13, P(het)=0.27) (data not shown).

Although, in the OXVASC study, we found that female probands were also more likely to have a history of stroke in sisters than in brothers, no similar data were available in previous published studies. Similarly, maternal excess in female probands was consistent across age group and stroke subtypes in the Oxfordshire studies,13 but we did not find any similar data in the literature.

Finally, to test whether the maternal excess of stroke could be explained by some artifact attributable to previous sex- and age-specific differences in stroke incidence, we used the data from the OCSP, which ascertained all incident strokes in our population from 1981 to 1986, ie, corresponding approximately to the period during which strokes were occurring in the parents of OXVASC patients.38 As shown in Table 2, the expected ratio of maternal to paternal strokes was less than 1 for events occurring under the age of 75 years, but the ratio reversed for strokes at older ages. In female probands under the age of 75 years in OXVASC, the observed excess of strokes in mothers was opposite to that expected. In male probands with stroke under age 75 years, the sex ratio for parental stroke was approximately unity but this possibly also represented a small excess of maternal stroke compared with that expected on the basis of OCSP incidence data.


View this table:
[in this window]
[in a new window]

 
Table 2. Comparison Between Ratio Women-Men in OCSP and Ratio Mothers-Fathers in OXVASC (Ratios of Crude Numbers)


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
This systematic review and meta-analysis of published and unpublished data shows that women are about 50% more likely to have a maternal than a paternal history of stroke whereas no similar excess exists in men. The present replication of our previous findings in Oxford studies across different continents and in various study designs shows that the finding is unlikely to be attributable to chance or to be a consequence of some unknown selection biases. The maternal excess that we have demonstrated in female probands but not in males is unlikely to be explained by any sex difference in life-time risk of stroke, which is very similar in women and men in incidence studies.14,39 Moreover, any explanation based on a greater incidence of ischemic stroke in women of the parental generation would not be consistent with our finding of no excess of maternal stroke in male probands. Although in earlier data from the Framingham cohort paternal history of stroke appeared to be a more potent risk factor for stroke in offsprings than maternal history,40 other studies found that maternal and paternal history of stroke provided a relatively similar increase in risk of stroke.24,36 However, sex-specific data are very scarce,36 and therefore, differences in risk of stroke associated with maternal or paternal history between male and female probands could not be excluded. Our result supports previous findings of distinct maternal and paternal influences on the risk of cardiovascular diseases.8,10,11,41 It is also plausible given that there are several other well-recognized differences between males and females with stroke and TIA.9

A higher maternal transmission has been observed in several other conditions predisposing to vascular diseases including diabetes mellitus, hypertension, and low HDL-cholesterol concentration,12,42–44 and has also been recently documented in coronary artery disease.45 As in these conditions, genetic and nongenetic factors could explain the excess maternal transmission and are not mutually exclusive. However, mother-to-daughter transmission cannot be explained easily by classical genetic mechanisms. Mitochondrial transmission of a genetic profile that had greater penetrance in females is theoretically possible but, to our knowledge, such an interaction between mitochondrial genome and sex of the proband has never been documented. Epigenetic phenomena could also account for our findings.46 They are changes in gene expression that do not entail a change in DNA sequence but have sufficient stability to be transmitted from parental cell to daughter cells. This occurs by altering the chromatin structure and includes covalent modifications of DNA and histones. Genomic imprinting is a subtype of epigenetic regulation in which the activity of a gene is reversibly modified depending on the sex of the parent that transmits it, leading to unequal expression of the maternal and the paternal alleles for a diploid locus. There is evidence that epigenotype, in particular imprinting genes, could be more susceptible to environmental factors (including maternal behavior in animal) than genotype,46,47 and interactions between imprinting phenomena and sex of the offspring have been suggested in other diseases.48

There are also potential nongenetic explanations for our findings. First, mothers and daughters could share environmental risk factors for stroke. In our previous analysis of OXVASC data, we did not find any relation with the traditional vascular risk factors, but there are other factors such as those related to childhood socioeconomic or psychological environment that could be relevant. For example, maternal influence on stress reactivity is well documented in rodents and humans.49 It has been hypothesized that childhood maternal environment influences the development of responses to stress, which form the basis for vulnerability/resistance to diseases in adulthood.49 Second, consequences of programming during the fetal life by maternal intrauterine environment or during early infancy are also plausible explanations.50,51 The fetal origins hypothesis proposes that coronary artery disease, type 2 diabetes, stroke, and hypertension originate in developmental plasticity, in response to adverse intrauterine environment during fetal life or rapid gains in weight during infancy.10 A number of sex-specific effects have been described in animal models of fetal programming, with females appearing to be more sensitive to some programming effects, and these results have been supported in a few human studies.41 Interestingly, there is evidence that fetal or early life programming and responses to stress are related to epigenetic modifications (ie, interactions between epigenotype and environmental factors).41,49

The maternal excess in women was greater in the 2 earliest studies (Figure 3)—the OCSP and Marshall study.33 This could be attributable to chance or to differences in the way of collecting family history data, but might also reflect changes over time in the prevalence of environmental factors which could interact with epigenotype or early life programming. Although the strength of the association was weaker in other data than in ours, the association was still highly significant in other data. The I2 value found in this analysis suggested high heterogeneity across studies. However, estimates showed the same direction of effect, with almost all studies showing a maternal excess in women.17

Several potential limitations need to be addressed. First, the accuracy and exhaustiveness of family history data may be questioned. Studies in which family history data were collected from patients’ reports could have inappropriately considered hemorrhagic strokes in parents as a positive family history. However, hemorrhagic strokes account for a small proportion of strokes and although probands could be unaware of the exact diagnosis in their parent, this potential bias is unlikely to be related to the sex of the proband. There is also potential differential accuracy in recall of family history between men and women, with women tending to report family history more accurately than males in some diseases.52 However, the Framingham offspring study showed that the accuracy of parental history reports did not differ between men and women for any risk factor or vascular disease, nor between maternal and paternal conditions.53 More importantly, because recall-bias can be a major problem in case–control studies we restricted our study to case–case comparisons. Anyway, it is unlikely that female probands would be expected to recall stroke in their mother to a substantially greater extent than stroke in their fathers. Therefore, none of these potential recall biases are likely to explain our findings. Second, some studies of our meta-analysis included a proportion of hemorrhagic strokes. However, we only included studies with a small proportion of hemorrhagic strokes (see Methods) and there was no heterogeneity across studies. Moreover, exclusion of studies in which hemorrhagic strokes were included did not change our results (data not shown). Third, it has been suggested that apparent maternal transmission of diabetes could partly be explained by coding "don’t know" responses as indicating no family history, with unknown paternal status being more common than unknown maternal status in that study.54 However, the bias was unrelated to the sex of the proband. Moreover, in OXVASC, we found that "don’t know" responses were rare and in fact slightly more common in female probands.13 Fourth, another potential bias could result from patients with severe or fatal stroke for whom family history is usually unknown. Yet, as suggested by a recent study, those patients may be more likely to have a positive family history.55 However, in that study, the association with severity was found with sibling history of stroke only and there was no evidence for interaction with the sex of the proband. Fifth, the longer average life span in women and the strong relation between age and stroke incidence result in bigger numbers of old women at risk of stroke and higher crude numbers of strokes in women than in men in the oldest categories of age (≥75 years). This could have explained a slight excess of maternal strokes in our analyses. However, the age-specific incidence of ischemic stroke is higher in men and overall incidences are the same in men and in women. Moreover, in OXVASC for example, the mean age of death of mothers was similar in male and female probands, and the maternal excess in women was observed across all categories of age.13 Considering an expected prevalence higher in fathers than in mothers from OCSP data, the excess of maternal history of stroke <75 years was in fact greater than twice in females. Although the analysis comparing OCSP data to OXVASC findings may have some limitations, it does not support that our results could be explained by any artifact due to sex- and age-specific differences in stroke incidence. Nevertheless, it remains to be demonstrated that there is no similar maternal excess in females in an appropriate control population. Finally, a small bias might be expected because of nonpaternity. However, rates of nonpaternity are not sufficiently high to account for the effect sizes that we observed and although they could lead to small apparently increased maternal heritability, this effect would not be dependent on the sex of the proband.

In summary, we have shown that women with stroke are more likely than men to have a parental history of stroke, and that this is accounted for by an excess maternal history of stroke in female probands. This finding is consistent across all available published and unpublished data and could be explained by sex-specific genetic, epigenetic, or nongenetic mechanisms.


*    Acknowledgments
 
We thank the following for providing unpublished data: Dr F. Vitullo (Laboratory of Epidemiology and Health Policy, Mario Negri Sud Institute, Italy); Dr G. Heiss (Department of Epidemiology, School of Public Health, Chapel Hill, NC); Dr K. Berger (Institute of Epidemiology and Social Medicine, Muenster, Germany); Dr M. Caicoya (Department of Clinical Epidemiology and Preventive Medicine, Oviedo, Spain); Drs W. Lalouschek, S. Tentschert (Department of Neurology, Vienna, Austria); Dr L.D. Lisabeth (Stroke Program, Ann Arbor, Mich); Drs A. Lindgren, H. Lövkvist, B. Norrving (Department of Neurology, Lund, Sweden). We also thank Dr Enrico Flossmann for help with the systematic review and all other staff and collaborators involved in the Oxford vascular Study.

Disclosures

None.

Received February 5, 2007; revision received May 15, 2007; accepted June 5, 2007.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke. 2004; 35: 212–227.[Abstract/Free Full Text]
  2. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain. 2000; 123: 1784–1812.[Abstract/Free Full Text]
  3. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, Jonsdottir T, Gudmundsdottir T, Bjarnadottir SM, Einarsson OB, Gudjonsdottir HM, Hawkins M, Gudmundsson G, Gudmundsdottir H, Andrason H, Gudmundsdottir AS, Sigurdardottir M, Chou TT, Nahmias J, Goss S, Sveinbjörnsdottir S, Valdimarsson EM, Jakobsson F, Agnarsson U, Gudnason V, Thorgeirsson G, Fingerle J, Gurney M, Gudbjartsson D, Frigge ML, Kong A, Stefansson K, Gulcher JR. The gene encoding phophodiesterase 4D confers risk of ischemic stroke. Nat Genet. 2003; 35: 131–138.[CrossRef][Medline] [Order article via Infotrieve]
  4. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, Stefansson K. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet. 2004; 36: 233–239.[CrossRef][Medline] [Order article via Infotrieve]
  5. Worall BB, Mychaleckyj JC. PDE4D and stroke. A real advance or a case of the Emperor’s new clothes? Stroke. 2006; 37: 1955–1957.[Free Full Text]
  6. Flossmann E, Rothwell PM. Family history of stroke in patients with transient ischemic attack in relation to hypertension and other intermediate phenotypes. Stroke. 2005; 36: 830–835.[Abstract/Free Full Text]
  7. Flossmann E, Schulz UG, Rothwell PM. Potential confounding by intermediate phenotypes in studies of the genetics of ischaemic stroke. Cerebrovasc Dis. 2005; 19: 1–10.[Medline] [Order article via Infotrieve]
  8. Barker DJ, Lackland DT. Prenatal influences on stroke mortality in England and Wales. Stroke. 2003; 34: 1598–1602.[Abstract/Free Full Text]
  9. Bushnell CD, Hurn P, Colton C, Miller VM, del Zoppo G, Elkind MS, Stern B, Herrington D, Ford-Lynch G, Gorelick P, James A, Brown CM, Choi E, Bray P, Newby LK, Goldstein LB, Simpkins J. Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke. 2006; 37: 2387–2399.[Abstract/Free Full Text]
  10. Barker DJP. The developmental origins of adult disease. Eur J Epidemiol. 2003; 18: 733–736.[Medline] [Order article via Infotrieve]
  11. Harding JE. The nutritional basis of the fetal origins of adult disease. Int J Epidemiol. 2001; 30: 15–23.[Free Full Text]
  12. Karter AJ, Rowell SE, Ackerson LM, Mitchell BD, Ferrara A, Selby JV, Newman B. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 1999; 22: 938–943.[Abstract]
  13. Touzé E, Rothwell PM. Heritability of ischaemic stroke in women compared with men: a genetic epidemiological study. Lancet Neurol. 2007; 6: 125–133.[CrossRef][Medline] [Order article via Infotrieve]
  14. Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, Redgrave JN, Bull LM, Welch SJ, Cuthbertson FC, Binney LE, Gutnikov SA, Anslow P, Banning AP, Mant D, Mehta Z. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 2005; 366: 1773–1783.[CrossRef][Medline] [Order article via Infotrieve]
  15. Bamford J, Sandercock P, Dennis M, Warlow C, Jones L, McPherson K, Vessey M, Fowler G, Molyneux A, Hughes T, Burn J, Wade D. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Prject 1981–86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry. 1988; 51: 1373–1380.[Abstract]
  16. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. Oxford: Blackwell; 2002.
  17. Higgins JPT, Thmpson SG, Deeks JJ, Altman DG. Measuring inconstistency in meta-analyses. BMJ. 2003; 327: 560.[Free Full Text]
  18. Lindgren A, Lovkvist H, Hallstrom B, Hoglund P, Jonsson AC, Kristoffersson U, Luthman H, Petersen B, Norrving B. Prevalence of stroke and vascular risk factors among first-degree relatives of stroke patients and control subjects. A prospective consecutive study. Cerebrovasc Dis. 2005; 20: 381–387.[Medline] [Order article via Infotrieve]
  19. Vitullo F, Marchioli R, Di Mascio R, Cavasinni L, Pasquale AD, Tognoni G. Family history and socioeconomic factors as predictors of myocardial infarction, unstable angina and stroke in an Italian population. PROGETTO 3A Investigators. Eur J Epidemiol. 1996; 12: 177–185.[Medline] [Order article via Infotrieve]
  20. Lisabeth LD, Kardia SL, Smith MA, Fornage M, Morgenstern LB. Family history of stroke among Mexican-American and non-Hispanic white patients with stroke and TIA: implications for the feasibility and design of stroke genetics research. Neuroepidemiology. 2005; 24: 96–102.[CrossRef][Medline] [Order article via Infotrieve]
  21. Tentschert S, Greisenegger S, Wimmer R, Lang W, Lalouschek W. Association of parental history of stroke with clinical parameters in patients with ischemic stroke or transient ischemic attack. Stroke. 2003; 34: 2114–2119.[Abstract/Free Full Text]
  22. Berger K, Schulte H, Stogbauer F, Assmann G. Incidence and risk factors for stroke in an occupational cohort: the PROCAM Study. Prospective Cardiovascular Muenster Study. Stroke. 1998; 29: 1562–1566.[Abstract/Free Full Text]
  23. Liao D, Myers R, Hunt S, Shahar E, Paton C, Burke G, Province M, Heiss G. Familial history of stroke and stroke risk. The Family Heart Study. Stroke. 1997; 28: 1908–1912.[Abstract/Free Full Text]
  24. Caicoya M, Corrales C, Rodriguez T. Family history and stroke: a community case–control study in Asturias, Spain. J Epidemiol Biostat. 1999; 4: 313–320.[Medline] [Order article via Infotrieve]
  25. Baweja G, Nanda NC, Parikh N, Bhatia V, Venkataraman R. Prevalence of stroke and associated risk factors in Asian Indians living in the state of Georgia, United States of America. Am J Cardiol. 2004; 93: 267–269.[CrossRef][Medline] [Order article via Infotrieve]
  26. Becher H, Grau A, Steindorf K, Buggle F, Hacke W. Previous infection and other risk factors for acute cerebrovascular ischaemia: attributable risks and the characterisation of high risk groups. J Epidemiol Biostat. 2000; 5: 277–283.[Medline] [Order article via Infotrieve]
  27. Alter M. Genetic factors in cerebrovascular accidents. Trans Am Neurol Assoc. 1967; 92: 205–208.[Medline] [Order article via Infotrieve]
  28. Kim H, Friedlander Y, Longstreth WT Jr, Edwards KL, Schwartz SM, Siscovick DS. Family history as a risk factor for stroke in young women. Am J Prev Med. 2004; 27: 391–396.[CrossRef][Medline] [Order article via Infotrieve]
  29. Lindenstrom E, Boysen G, Nyboe J. Risk factors for stroke in Copenhagen, Denmark. I. Basic demographic and social factors. Neuroepidemiology. 1993; 12: 37–42.[Medline] [Order article via Infotrieve]
  30. Reed T, Kirkwood SC, DeCarli C, Swan GE, Miller BL, Wolf PA, Jack LM, Carmelli D. Relationship of family history scores for stroke and hypertension to quantitative measures of white-matter hyperintensities and stroke volume in elderly males. Neuroepidemiology. 2000; 19: 76–86.[CrossRef][Medline] [Order article via Infotrieve]
  31. MacClellan LR, Mitchell BD, Cole JW, Wozniak MA, Stern BJ, Giles WH, Brown DW, Sparks MJ, Kittner SJ. Familial aggregation of ischemic stroke in young women: the stroke prevention in young women study. Genet Epidemiol. 2006; 30: 602–608.[CrossRef][Medline] [Order article via Infotrieve]
  32. Gifford AJ. An epidemiological study of cerebrovascular disease. Am J Public Health. 1966; 56: 452–461.[Free Full Text]
  33. Marshall J. Familial incidence of cerebrovascular disease. J Med Gen. 1971; 8: 84–89.[Medline] [Order article via Infotrieve]
  34. Starr J, Rush M, De Mey R, Dennis M. Parental causes of death in stroke. Cerebrovasc Dis. 2001; 11: 65–70.[CrossRef][Medline] [Order article via Infotrieve]
  35. Welin L, Svardsudd K, Wilhelmsen L, Larsson B, Tibblin G. Analysis of risk facotors for stroke in a cohort of men born in 1913. N Engl J Med. 1987; 317: 521–526.[Abstract]
  36. Jousilahti P, Rastenyte D, Tuomilehto J, Sarti C, Vartiainen E. Parental history of cardiovascular disease and risk of stroke: A prospective follow-up of 14 371 middle-aged men and women in Finland. Stroke. 1997; 28: 1361–1366.[Abstract/Free Full Text]
  37. Gertler MM, Rusk HA, Whiter HH, Leetma HE, Ehrenkranz M. Ischemic cerebrovascular disease. The assessment of risk factors. Geriatrics. 1968; 23: 135–141.[Medline] [Order article via Infotrieve]
  38. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, Gutnikov SA, Edwards P, Mant D, Sackley CM, Farmer A, Sandercock PA, Dennis MS, Warlow CP, Bamford JM, Anslow P. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004; 363: 1925–1933.[CrossRef][Medline] [Order article via Infotrieve]
  39. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003; 2: 43–53.[CrossRef][Medline] [Order article via Infotrieve]
  40. Kiely DK, Wolf PA, Cupples LA, Beiser AS, Myers RH. Familial aggregation of stroke. The Framingham Study. Stroke. 1993; 24: 1366–1371.[Abstract/Free Full Text]
  41. Drake AJ, Walker BR. The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J Endocrinol. 2004; 180: 1–16.[Abstract]
  42. Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, Roumain J, Bennett PH, Knowler WC. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000; 49: 2208–2211.[CrossRef][Medline] [Order article via Infotrieve]
  43. DeStefano AL, Gavras H, Heard-Costa N, Bursztyn M, Manolis A, Farrer LA, Baldwin CT, Gavras I, Schwartz F. Maternal component in the familial aggregation of hypertension. Clin Genet. 2001; 60: 13–21.[CrossRef][Medline] [Order article via Infotrieve]
  44. Poulsen P, Vaag A, Kyvik K, Beck-Nielsen H. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia. 2001; 44: 537–543.[CrossRef][Medline] [Order article via Infotrieve]
  45. Sundquist K, Li X. Differences in maternal and paternal transmission of coronary heart disease. Am J Prev Med. 2006; 30: 480–486.[CrossRef][Medline] [Order article via Infotrieve]
  46. Jiang YH, Bressler J, Beaudet AL. Epigenetics and human disease. Annu Rev Genomics Hum Genet. 2004; 5: 479–510.[CrossRef][Medline] [Order article via Infotrieve]
  47. Weaver IC, Cervoni N, Champagne FA, D’Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. Epigenetic programming by maternal behavior. Nat Neurosci. 2004; 7: 847–854.[CrossRef][Medline] [Order article via Infotrieve]
  48. Kovtun IV, Therneau TM, McMurray CT. Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington’s disease gene. Hum Mol Genet. 2000; 9: 2767–2775.[Abstract/Free Full Text]
  49. Cameron NM, Champagne FA, Parent C, Fish EW, Ozaki-Kuroda K, Meaney MJ. The programming of individual differences in defensive responses and reproductive strategies in the rat through variations in maternal care. Neurosci Biobehav Rev. 2005; 29: 843–865.[CrossRef][Medline] [Order article via Infotrieve]
  50. Barker DJ. Fetal origins of coronary heart disease. BMJ. 1995; 311: 171–174.[Free Full Text]
  51. Singhal A, Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis? Lancet. 2004; 363: 1642–1645.[CrossRef][Medline] [Order article via Infotrieve]
  52. Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO. Reliability of self-reported family history of cancer in a large case–control study of lymphoma. J Natl Cancer Inst. 2006; 98: 61–68.[Abstract/Free Full Text]
  53. Murabito JM, Nam BH, D’Agostino RB Sr, Lloyd-Jones DM, O’Donnell CJ, Wilson PW. Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med. 2004; 140: 434–440.[Abstract/Free Full Text]
  54. Thorand B, Liese AD, Metzger MH, Reitmeir P, Schneider A, Lowel H. Can inaccuracy of reported parental history of diabetes explain the maternal transmission hypothesis for diabetes? Int J Epidemiol. 2001; 30: 1084–1089.[Abstract/Free Full Text]
  55. Meschia JF, Case LD, Worrall BB, Brown RD Jr, Brott TG, Frankel M, Silliman S, Rich SS. Family history of stroke and severity of neurologic deficit after stroke. Neurology. 2006; 67: 1396–1402.[Abstract/Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/1/16    most recent
STROKEAHA.107.484618v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touzé, E.
Right arrow Articles by Rothwell, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touzé, E.
Right arrow Articles by Rothwell, P. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Clinical genetics
Right arrow Epidemiology
Right arrow Genetics of Stroke